Region Head and Market Access leader (assignment) @ Shire
Country Medical Head, Medical and Price and Reimbursement Department, Italy @ Shire
Donatello Crocetta's Education
IMD
Stakeholders management for Boards
2022 - 2022
IMD
Finance for Boards
2022 - 2022
IMD
Digital transformation for Boards
2022 - 2022
IMD Business School
High Performance Board Program (Board Governance, Company Strategy, ESG Governance, Business Management)
2021 - 2021
Bologna Business School
Executive Master of Business Administration (E.M.B.A.) Graduate school (Executive MBA- EFMD accredited, 2y (Marketing, Finance, Technical Operations, People Management))
2005 - 2007
Università degli Studi di Bari
Doctor of Medicine and Surgery (M.D.) and European Medical License (Medicine)
1991 - 1997
SSPH+ Summer School in Public Health Policy, Economics and Management in Lugano
Methodology and Practical Applications of Economic Evaluation and HTA in Health Care (Health Economics)
Donatello Crocetta, based in Zug, ZG, CH, is currently a SVP Global Head of Rare Disease ( Access, Marketing , Policies, Operations) and Head of Rare Medical at UCB, bringing experience from previous roles at UCB, Takeda, Shire and Alnylam Pharmaceuticals. Donatello Crocetta holds a 2022 - 2022 Stakeholders management for Boards @ IMD. With a robust skill set that includes Pharmaceutical Industry, Market Access, Product Launch, Sales Effectiveness, Medical Affairs and more, Donatello Crocetta contributes valuable insights to the industry. Donatello Crocetta has 2 emails and 1 mobile phone number on RocketReach.